Biological_NP and_CC Biochemical_NP Characterization_NP of_IN Sheep_NP Scrapie_NP in_IN Japan_NP Due_NP to_TO the_DT apparent_JJ absence_NN of_IN an_DT agent-specific_JJ nucleic_JJ acid_NN genome_NN ,_, scrapie_NN strains_NNS cannot_MD be_VB classified_VBN by_IN genome_NN characterization_NN ,_, which_WDT is_VBZ commonly_RB used_VBN for_IN the_DT classification_NN of_IN many_JJ viruses_NNS ._SENT However_RB ,_, scrapie_NN strains_NNS can_MD be_VB distinguished_VBN to_TO some_DT extent_NN by_IN biological_JJ properties_NNS such_JJ as_IN transmissibility_NN to_TO experimental_JJ animals_NNS and_CC distribution_NN of_IN neuropathological_JJ lesions_NNS and_CC by_IN biochemical_JJ properties_NNS such_JJ as_IN the_DT molecular_JJ mass_NN and_CC relative_JJ protease-resistance_NN of_IN the_DT disease-specific_JJ isoform_NN of_IN prion_NN protein_NN (_( PrPSc_NP )_) ._SENT In_IN order_NN to_TO preliminarily_RB characterize_VB the_DT scrapie_NN strains_NNS that_WDT are_VBP prevalent_JJ in_IN Japan_NP ,_, we_PP analyzed_VBD the_DT transmissibility_NN of_IN sheep_NN scrapie_NN isolates_VBZ to_TO mice_NNS and_CC the_DT relative_JJ proteinase_NN K_NP (_( PK_NP )_) resistance_NN of_IN the_DT corresponding_JJ PrPSc_NP ._SENT The_DT results_NNS indicate_VBP that_IN Japanese_JJ scrapie_NN strains_NNS can_MD be_VB divided_VBN into_IN at_IN least_JJS three_CD groups_NNS based_VBN on_IN biological_JJ and_CC biochemical_JJ properties_NNS ._SENT The_DT first_JJ group_NN includes_VBZ isolates_NNS which_WDT cause_VBP disease_NN in_IN mice_NNS with_IN an_DT incubation_NN period_NN of_IN similar400_JJ days_NNS and_CC possess_VB PrPSc_NP with_IN relatively_RB high_JJ PK_NP resistance_NN ._SENT Isolates_NNS of_IN the_DT second_JJ group_NN contain_VBP PrPSc_NN that_WDT is_VBZ highly_RB resistant_JJ to_TO PK_NP digestion_NN but_CC transmit_VB poorly_RB to_TO mice_NNS ._SENT The_DT final_JJ group_NN consists_VBZ of_IN isolates_NNS that_WDT cause_VBP disease_NN in_IN mice_NNS with_IN an_DT incubation_NN period_NN of_IN less_JJR than_IN 300_CD days_NNS and_CC are_VBP associated_VBN with_IN PrPSc_NP with_IN reduced_VBN PK_NP resistance_NN ._SENT Sheep_NP scrapie_NP has_VBZ occurred_VBN sporadically_RB in_IN Japan_NP since1982_NN ,_, with_IN only_JJ similar60_NN officially_RB reported_VBD cases_NNS so_RB far_RB ._SENT However_RB ,_, the_DT diversity_NN of_IN scrapie_NN strains_NNS in_IN the_DT field_NN suggested_VBD by_IN our_PP$ data_NN raises_VBZ the_DT concern_NN that_IN a_DT scrapie_NN strain_NN similar_JJ to_TO the_DT parental_JJ agent_NN of_IN bovine_JJ spongiform_JJ encephalopathy_NN could_MD exist_VB or_CC emerge_VB in_IN Japan_NP ._SENT Thus_RB ,_, continuous_JJ surveillance_NN for_IN scrapie_NN will_MD be_VB required_VBN to_TO prevent_VB the_DT further_JJR spread_NN of_IN scrapie_NN ,_, not_RB only_RB among_IN the_DT sheep_NN population_NN but_CC also_RB to_TO other_JJ species_NNS ,_, and_CC to_TO eliminate_VB any_DT potential_JJ risk_NN of_IN sheep_NN scrapie_NN to_TO public_JJ health_NN ._SENT Transmissible_JJ spongiform_JJ encephalopathies_NNS (_( TSEs_NNS )_) are_VBP fatal_JJ neurodegenerative_JJ diseases_NNS ,_, which_WDT include_VBP scrapie_NN in_IN sheep_NN and_CC goats_NNS ,_, bovine_JJ spongiform_JJ encephalopathy_NN (_( BSE_NP )_) ,_, and_CC Creutzfeldt-Jakob_NP disease_NN (_( CJD_NN )_) in_IN humans_NNS ._SENT Scrapie_NP has_VBZ existed_VBN for_IN more_JJR than_IN two_CD centuries_NNS ,_, while_IN BSE_NP was_VBD first_RB recognized_VBN in_IN 1985_CD ,_, followed_VBN by_IN a_DT BSE_JJ epidemic_NN in_IN the_DT United_NP Kingdom_NP ._SENT Epidemiological_JJ studies_NNS suggested_VBD that_IN BSE_NP was_VBD primarily_RB caused_VBN by_IN feeding_VBG meat_NN and_CC bone_NN meal_NN (_( MBM_NP )_) contaminated_VBD with_IN scrapie_NN agent_NN to_TO cattle_NNS ._SENT Once_IN BSE_NP appeared_VBD ,_, the_DT causative_JJ agent_NN spread_VBN through_IN the_DT cattle_NNS population_NN by_IN the_DT use_NN of_IN BSE_JJ agent-contaminated_JJ MBM_NN ._SENT The_DT appearance_NN of_IN feline_JJ spongiform_JJ encephalopathy_NN (_( FSE_NN )_) in_IN domestic_JJ and_CC captive_JJ cats_NNS and_CC ,_, more_RBR recently_RB ,_, variant_JJ CJD_NNS (_( vCJD_NN )_) in_IN humans_NNS in_IN 1996_CD ,_, has_VBZ raised_VBN a_DT global_JJ concern_NN for_IN the_DT spread_NN of_IN the_DT BSE_JJ agent_NN to_TO other_JJ species_NNS via_IN the_DT food_NN chain_NN ._SENT It_PP is_VBZ known_VBN that_IN there_EX are_VBP biologically_RB distinguishable_JJ sheep_NN scrapie_NN strains_NNS in_IN the_DT United_NP Kingdom_NP ;_: however_RB ,_, BSE_NP isolates_NNS studied_VBD so_RB far_RB appear_VBP to_TO have_VB comparatively_RB uniform_JJ characteristics_NNS ._SENT The_DT biological_JJ and_CC biochemical_JJ properties_NNS of_IN the_DT BSE_JJ agent_NN are_VBP very_RB similar_JJ to_TO those_DT of_IN the_DT agents_NNS of_IN vCJD_NN and_CC FSE_NN ,_, providing_VBG strong_JJ evidence_NN that_IN cross-species_NNS transmission_NN of_IN BSE_NN to_TO humans_NNS and_CC felids_NNS resulted_VBN in_IN vCJD_NN and_CC FSE_NN ,_, respectively_RB ._SENT Thus_RB ,_, it_PP is_VBZ now_RB probable_JJ that_IN a_DT particular_JJ scrapie_NN strain_NN ,_, which_WDT possessed_VBD enhanced_JJ resistance_NN to_TO heat_VB inactivation_NN ,_, survived_VBD the_DT rendering_NN process_NN and_CC was_VBD transmitted_VBN to_TO cattle_NNS via_IN contaminated_JJ MBM_NP ._SENT Thereafter_RB ,_, the_DT agent_NN passed_VBN into_IN humans_NNS ,_, possibly_RB via_IN the_DT food_NN chain_NN ._SENT Alternatively_RB ,_, a_DT particular_JJ strain_NN capable_JJ of_IN infecting_VBG both_DT cattle_NNS and_CC humans_NNS might_MD have_VB been_VBN selected_VBN and_CC amplified_VBN during_IN the_DT transmission_NN of_IN the_DT scrapie_NN agent_NN to_TO cattle_NNS ._SENT One_CD of_IN the_DT characteristics_NNS of_IN TSEs_NP is_VBZ an_DT accumulation_NN of_IN a_DT protease-resistant_JJ ,_, abnormal_JJ isoform_NN of_IN a_DT host_NN protein_NN ,_, PrPSc_NP ,_, which_WDT is_VBZ specifically_RB detected_VBN in_IN the_DT central_JJ nervous_JJ system_NN and_CC lymphoid_JJ tissues_NNS of_IN scrapie-affected_JJ animals_NNS ._SENT PrPSc_NP is_VBZ posttranslationally_RB generated_VBN from_IN the_DT host-encoded_JJ sialoglycoprotein_NN ,_, prion_NN protein_NN (_( PrPC_NP )_) ._SENT PrPC_NP and_CC PrPSc_NP have_VBP the_DT same_JJ primary_JJ structure_NN but_CC different_JJ conformations_NNS as_IN detected_VBN by_IN analysis_NN of_IN biophysical_JJ properties_NNS and_CC biochemical_JJ properties_NNS ,_, such_JJ as_IN resistance_NN to_TO protease_NN digestion_NN and_CC solubility_NN in_IN nonionic_JJ detergent_NN ._SENT The_DT presence_NN of_IN PrPSc_NP usually_RB correlates_VBZ with_IN scrapie_NN infectivity_NN ._SENT Thus_RB ,_, PrPSc_NP is_VBZ thought_VBN to_TO be_VB one_CD of_IN the_DT major_JJ components_NNS of_IN the_DT scrapie_NN agent_NN ,_, and_CC so_RB detection_NN of_IN PrPSc_NP is_VBZ often_RB considered_VBN an_DT indication_NN of_IN the_DT presence_NN of_IN infectivity_NN ._SENT Although_IN the_DT exact_JJ nature_NN of_IN the_DT scrapie_NN agent_NN is_VBZ still_RB controversial_JJ ,_, the_DT failure_NN to_TO find_VB an_DT agent-specific_JJ genome_NN to_TO date_NN prevents_VBZ the_DT use_NN of_IN nucleic_JJ acid_NN sequencing_VBG for_IN strain_NN characterization_NN ,_, a_DT method_NN commonly_RB used_VBN for_IN strain_NN typing_VBG of_IN viruses_NNS and_CC bacteria_NNS ._SENT However_RB ,_, TSE_NP agents_NNS can_MD be_VB distinguished_VBN to_TO some_DT extent_NN by_IN incubation_NN periods_NNS and_CC distribution_NN of_IN neuropathological_JJ lesions_NNS on_IN transmission_NN to_TO experimental_JJ animals_NNS ,_, as_RB well_RB as_IN biochemical_JJ properties_NNS ,_, such_JJ as_IN relative_JJ protease_NN resistance_NN and/or_CC molecular_JJ mass_NN of_IN PrPSc_NP and_CC differences_NNS in_IN the_DT ratio_NN of_IN glycosylated_JJ PrPSc_NP bands_NNS ._SENT There_EX is_VBZ a_DT sporadic_JJ occurrence_NN of_IN scrapie_NN in_IN Japan_NP ,_, and_CC the_DT existence_NN of_IN BSE_NP was_VBD disclosed_VBN in_IN September_NP 2001_CD ._SENT Since_IN BSE_NN is_VBZ thought_VBN to_TO originate_VB from_IN sheep_NN scrapie_NN ,_, surveillance_NN of_IN scrapie-positive_JJ sheep_NN and_CC characterization_NN of_IN prevalent_JJ scrapie_NN strains_NNS in_IN the_DT field_NN are_VBP required_VBN for_IN the_DT prediction_NN and_CC elimination_NN of_IN a_DT potential_JJ risk_NN of_IN scrapie_NN to_TO public_JJ health_NN ._SENT In_IN order_NN to_TO attempt_VB to_TO characterize_VB scrapie_NN strains_NNS present_JJ in_IN Japan_NP ,_, we_PP analyzed_VBD several_JJ isolates_NNS for_IN their_PP$ transmissibility_NN to_TO mice_NNS and_CC the_DT biochemical_JJ properties_NNS of_IN the_DT associated_VBN PrPSc_NP ._SENT The_DT results_NNS showed_VBD that_IN at_IN least_JJS three_CD different_JJ strains_NNS of_IN scrapie_NN agent_NN exist_VBP in_IN Japan_NP ._SENT Sheep_NN with_IN scrapie_NN ._SENT |_SYM Eight_NP naturally_RB occurring_VBG sheep_NN scrapie_NN isolates_VBZ (_( KH2_NP ,_, KU_NP ,_, SB_NP ,_, Y2_NP ,_, Y5_NP ,_, S1_NP ,_, S2_NP ,_, and_CC S3_NP )_) collected_VBD from_IN 1987_CD to_TO 1996_CD and_CC three_CD first-passage_NN isolates_NNS from_IN experimental_JJ sheep_NN scrapie_NN infections_NNS (_( A1_JJ ,_, B3_NP ,_, and_CC G1_NP )_) were_VBD used_VBN in_IN this_DT study_NN ._SENT As_IN a_DT negative_JJ control_NN ,_, one_CD sheep_NN (_( S4_NP )_) ,_, which_WDT was_VBD defined_VBN as_IN negative_JJ for_IN scrapie_NN by_IN the_DT absence_NN of_IN both_DT neuronal_JJ vacuolation_NN in_IN histopathological_JJ examination_NN and_CC detectable_JJ PrPSc_NN in_IN central_JJ nervous_JJ system_NN and_CC lymphoid_JJ tissues_NNS in_IN immunoblot_NN analysis_NN ,_, was_VBD also_RB used_VBN ._SENT Sheep_NP S1_NP ,_, S2_NP ,_, S3_NP ,_, and_CC S4_NP were_VBD kept_VBN on_IN ranch_NN S._NP Sheep_NP S1_NP ,_, S2_NP ,_, and_CC S3_NP had_VBD been_VBN born_VBN from_IN two_CD ewes_NNS which_WDT showed_VBD neurological_JJ dysfunction_NN several_JJ months_NNS after_IN delivery_NN and_CC were_VBD diagnosed_VBN with_IN scrapie_NN by_IN clinical_JJ and/or_CC histopathological_JJ methods_NNS ._SENT The_DT sheep_NN S1_NP ,_, S2_NP ,_, and_CC S3_NP shared_VBD the_DT same_JJ sire_NN ._SENT However_RB ,_, there_EX were_VBD no_DT disease-associated_JJ mutations_NNS in_IN the_DT PrP_NP genes_NNS of_IN these_DT sheep_NN ,_, and_CC thus_RB the_DT sheep_NN S1_NP ,_, S2_NP ,_, and_CC S3_NP were_VBD tentatively_RB grouped_VBN as_IN cases_NNS of_IN endemic_JJ scrapie_NN ._SENT Sheep_NP KH2_NP ,_, KU_NP ,_, and_CC SB_NP ,_, each_DT from_IN independent_JJ ranches_NNS ,_, and_CC sheep_NN Y2_NP and_CC Y5_NP from_IN ranch_NN Y_NN ,_, were_VBD grouped_VBN as_IN sporadic_JJ cases_NNS because_IN there_EX is_VBZ no_DT immediate_JJ blood_NN relationship_NN among_IN these_DT sheep_NN ._SENT Sheep_NP A1_JJ and_CC B3_NP with_IN experimental_JJ scrapie_NN received_VBD the_DT same_JJ brain_NN homogenate_NN of_IN a_DT scrapie-affected_JJ sheep_NN that_WDT was_VBD not_RB included_VBN in_IN the_DT natural_JJ scrapie_NN group_NN used_VBN here_RB ,_, and_CC the_DT results_NNS of_IN experimental_JJ transmission_NN of_IN this_DT sheep_NN scrapie_NN isolate_VBP to_TO mice_NNS were_VBD reported_VBN elsewhere_RB ._SENT Sheep_NP G1_NP was_VBD inoculated_VBN intravenously_RB with_IN a_DT 10_CD %_NN brain_NN homogenate_NN of_IN scrapie-affected_JJ sheep_NN Y4_NP from_IN the_DT Y_NP ranch_NN ._SENT Sheep_NP Y2_NP ,_, Y4_NP ,_, and_CC Y5_NP were_VBD grown_VBN on_IN the_DT same_JJ farm_NN and_CC developed_VBN scrapie_NN within_IN 6_CD months_NNS ,_, but_CC they_PP were_VBD born_VBN to_TO different_JJ ewes_NNS ._SENT PrP_NP genotyping_NN of_IN sheep_NN ._SENT |_SYM PrP_NP genotyping_NN of_IN sheep_NN was_VBD performed_VBN as_IN described_VBN previously_RB ._SENT Amino_NN acid_NN polymorphisms_NNS at_IN codons_NNS 112_NP Met/Thr_NP ,_, 136_CD Ala/Val_NP ,_, 154_CD Arg/His_NP ,_, and_CC 171_CD Gln/Arg/His_NNS were_VBD basically_RB used_VBN for_IN distinction_NN of_IN the_DT PrP_NP genotype_NN ._SENT Bioassay_NN ._SENT |_SYM Twenty_NP microliters_NNS of_IN 10_CD %_NN brain_NN homogenates_NNS (_( in_IN phosphate-buffered_JJ saline_NN )_) from_IN scrapie-affected_JJ or_CC scrapie-negative_JJ sheep_NN were_VBD inoculated_VBN intracerebrally_RB into_IN 4-week-old_JJ female_JJ ICR_NP mice_NNS (_( PrP_NP allotype_NP PrPA/A_NP ;_: PrPA_NP encodes_VBZ PrP_NP with_IN codons_NNS 108_JJ Leu_NP and_CC 189_NP Thr_NP )_) ._SENT In_IN some_DT cases_NNS I/LnJ_NP mice_NNS (_( PrP_NP allotype_NP PrPB/B_NP ;_: PrPB_NP encodes_VBZ PrP_NP with_IN codons_NNS 108_JJ Phe_NP and_CC 189_NP Val_NP )_) were_VBD also_RB used_VBN ._SENT When_WRB mice_NNS showed_VBD clinical_JJ symptoms_NNS of_IN the_DT terminal_JJ stage_NN of_IN scrapie_NN ,_, mice_NNS were_VBD sacrificed_VBN under_IN anesthesia_NN and_CC brains_NNS were_VBD removed_VBN and_CC processed_VBN for_IN the_DT detection_NN of_IN PrPSc_NP ._SENT The_DT brains_NNS of_IN mice_NNS that_WDT died_VBD of_IN unknown_JJ causes_NNS were_VBD also_RB checked_VBN for_IN the_DT presence_NN of_IN PrPSc_NP ._SENT Sample_NN preparation_NN and_CC PK_NP digestion_NN ._SENT |_SYM Preparation_NN of_IN brain_NN samples_NNS for_IN proteinase_NN K_NP (_( PK_NP )_) digestion_NN was_VBD carried_VBN out_RP as_RB described_VBN elsewhere_RB with_IN slight_JJ modifications_NNS ._SENT Brains_NNS were_VBD homogenized_VBN with_IN 7_CD volumes_NNS (_( wt/vol_NN )_) of_IN 10_CD mM_NP Tris-HCl_NP (_( pH_NN 7.5_CD )_) and_CC 7.5_CD mM_NP MgCl2_NP ,_, and_CC the_DT homogenates_NNS were_VBD incubated_VBN at_IN 37C_JJ for_IN 1_CD h_NN with_IN DNase_NP I_NP (_( 40_CD mug/100_NN mg_NN tissue_NN )_) ._SENT After_IN adding_VBG 20_CD %_NN Sarkosyl_NN to_TO a_DT final_JJ concentration_NN of_IN 5_CD %_NN ,_, the_DT homogenates_NNS were_VBD kept_VBN at_IN room_NN temperature_NN (_( RT_NP )_) for_IN 30_CD min_NN and_CC then_RB centrifuged_VBN at_IN 12,000_CD x_NN g_NN at_IN RT_NP for_IN 5_CD min_NN ._SENT The_DT resulting_VBG supernatants_NNS were_VBD transferred_VBN to_TO new_JJ tubes_NNS ,_, and_CC then_RB solid_JJ NaCl_NP was_VBD added_VBN to_TO give_VB a_DT final_JJ concentration_NN of_IN 10_CD %_NN ._SENT After_IN a_DT 16-h_NP incubation_NN at_IN 4C_JJ with_IN continuous_JJ rotation_NN ,_, the_DT homogenates_NNS were_VBD centrifuged_VBN at_IN 16,000_CD x_NN g_NN ,_, 4C_JJ and_CC ,_, for_IN 40_CD min_NN ,_, and_CC the_DT resulting_VBG pellet_NN was_VBD resuspended_VBN in_IN 10_CD mM_NP Tris-HCl_NP (_( pH_NN 7.5_CD )_) ._SENT This_DT suspension_NN was_VBD subjected_VBN to_TO PK_NP digestion_NN at_IN various_JJ PK_NP concentrations_NNS and_CC times_NNS as_RB indicated_VBD in_IN each_DT experiment_NN ._SENT Phenylmethylsulfonyl_NN fluoride_NN (_( PMSF_NP )_) was_VBD added_VBN to_TO stop_VB the_DT digestion_NN (_( final_JJ conc_NN ._SENT 1_CD mM_NNS )_) ,_, and_CC then_RB the_DT reaction_NN mixture_NN was_VBD adjusted_VBN to_TO 4_CD %_NN sodium_NN dodecyl_NN sulfate_NN (_( SDS_NP )_) and_CC boiled_VBD for_IN 5_CD min_NN ._SENT The_DT proteins_NNS were_VBD precipitated_VBN with_IN 10_CD volumes_NNS of_IN ice-cold_JJ methanol_NN ,_, and_CC the_DT final_JJ pellet_NN was_VBD dissolved_VBN by_IN SDS-polyacrylamide_NP gel_NN electrophoresis_NN in_IN sample_NN buffer_NN (_( 4_CD %_NN SDS_NP ,_, 5_CD %_NN 2-mercaptoethanol_JJ ,_, 5_CD %_NN glycerol_NN ,_, 0.01_CD %_NN bromophenol_NN blue_JJ ,_, 62.5_CD mM_NP Tris-HCl_NP [_SYM pH_NN 6.8_CD ]_SYM )_) ._SENT Detection_NN of_IN PrPSc_NP ._SENT (_( i_NP )_) Immunoblot_NP analysis_NN ._SENT |_SYM Immunoblot_NP analysis_NN was_VBD carried_VBN out_RP as_RB described_VBN previously_RB with_IN B-103_NP rabbit_NN serum_NN ._SENT Densitometric_JJ analysis_NN of_IN X-ray_NN film_NN was_VBD performed_VBN with_IN a_DT Lane_NP &_CC Spot_NP Analyzer_NP (_( Atto_NP ,_, Tokyo_NP ,_, Japan_NP )_) ._SENT (_( ii_NP )_) Dot_NP blot_NN analysis_NN ._SENT |_SYM The_DT 10_CD %_NN brain_NN homogenates_NNS of_IN sheep_NN with_IN scrapie_NN were_VBD mixed_VBN with_IN an_DT equal_JJ volume_NN of_IN cold_JJ lysis_NN buffer_NN [_SYM 0.5_CD %_NN Nonidet_NP P-40_NP ,_, 0.5_CD %_NN sodium_NN deoxycholate_NN ,_, 10_CD mM_NP EDTA_NP ,_, 100_CD mM_NP NaCl_NP ,_, 50_CD mM_NP Tris-HCl_NP (_( pH_NN 7.4_CD )_) ]_SYM ,_, diluted_VBN serially_RB in_IN twofold_JJ steps_NNS and_CC blotted_VBN onto_IN a_DT nitrocellulose_NN membrane_NN ._SENT The_DT membrane_NN was_VBD dried_VBN and_CC then_RB washed_VBN with_IN Tris-buffered_JJ saline_NN containing_VBG 0.1_CD %_NN Tween_NP 20_CD (_( TBST_NP )_) ._SENT The_DT membrane_NN was_VBD treated_VBN with_IN PK_NP (_( 25_CD mug/ml_NN )_) in_IN TBST_NP at_IN 37C_JJ for_IN 1_CD h_NN ,_, and_CC the_DT reaction_NN was_VBD stopped_VBN by_IN adding_VBG PMSF_NN to_TO a_DT final_JJ concentration_NN of_IN 2_CD mM_NNS ._SENT After_IN washing_NN with_IN TBST_NP ,_, the_DT membrane_NN was_VBD treated_VBN with_IN 3_CD M_NP guanidinium_NN isothiocyanate_NN for_IN 20_CD min_NN at_IN RT_NP and_CC washed_VBN with_IN TBST_NP again_RB ._SENT Immunostaining_VBG of_IN the_DT membrane_NN was_VBD then_RB performed_VBN as_IN described_VBN for_IN the_DT immunoblot_NN analysis_NN ._SENT Sheep_NN with_IN scrapie_NN ._SENT |_SYM Characteristics_NP of_IN the_DT sheep_NN used_VBN in_IN this_DT study_NN are_VBP summarized_VBN in_IN Table_NP ._SENT The_DT major_JJ symptoms_NNS of_IN all_DT scrapie_NN cases_NNS used_VBD here_RB were_VBD ataxia_NN and_CC ,_, at_IN the_DT terminal_JJ stage_NN ,_, astasia_NN ._SENT No_DT sheep_NN except_IN for_IN KU_NP showed_VBD obvious_JJ loss_NN of_IN fleece_NN ,_, which_WDT is_VBZ thought_VBN to_TO be_VB caused_VBN by_IN pruritus_NN ._SENT The_DT sheep_NN S1_NP ,_, S2_NP ,_, and_CC S3_NP ,_, which_WDT were_VBD tentatively_RB grouped_VBN as_IN cases_NNS of_IN endemic_JJ scrapie_NN (_( see_VB Materials_NNS and_CC Methods_NNS )_) ,_, differed_VBN from_IN other_JJ sheep_NN with_IN scrapie_NN ._SENT They_PP showed_VBD hypersensitivity_NN at_IN the_DT onset_NN of_IN disease_NN and_CC died_VBD of_IN scrapie_NN at_IN a_DT considerably_RB young_JJ age_NN (_( average_JJ ,_, 16.3_CD months_NNS old_JJ )_) compared_VBN to_TO sheep_NN with_IN scrapie_NN grouped_VBN as_IN sporadic_JJ cases_NNS here_RB (_( average_JJ ,_, 42.0_CD months_NNS old_JJ )_) or_CC those_DT described_VBN by_IN others_NNS (_( 2_CD to_TO 6_CD years_NNS old_JJ )_) ._SENT Transmissibility_NN of_IN sheep_NN scrapie_NN to_TO mice_NNS ._SENT |_SYM Transmission_NP of_IN 11_CD sheep_NN scrapie_NN samples_NNS to_TO mice_NNS is_VBZ shown_VBN in_IN Table_NP ._SENT Eight_CD of_IN 11_CD successfully_RB transmitted_VBN to_TO ICR_NP mice_NNS (_( PrP_NP allotype_NP ,_, PrPA/A_NP )_) ,_, with_IN average_JJ incubation_NN periods_NNS from_IN 229_CD to_TO 451_CD days_NNS postinfection_NN (_( dpi_NN )_) ._SENT These_DT eight_CD sheep_NN scrapie_NN samples_NNS seem_VBP to_TO be_VB divided_VBN into_IN two_CD groups_NNS based_VBN on_IN the_DT incubation_NN periods_NNS ;_: one_PP includes_VBZ A1_JJ and_CC B3_NP ,_, which_WDT transmitted_VBD to_TO mice_NNS with_IN incubation_NN periods_NNS of_IN around_RB 230_CD dpi_NNS ,_, and_CC the_DT other_JJ includes_VBZ KH2_NP ,_, KU_NP ,_, SB_NP ,_, Y2_NP ,_, Y5_NP ,_, and_CC G1_NP ,_, which_WDT caused_VBD disease_NN in_IN mice_NNS with_IN incubation_NN periods_NNS of_IN similar386_NN to_TO 451_CD dpi_NNS ._SENT There_EX is_VBZ no_DT significant_JJ difference_NN among_IN the_DT incubation_NN periods_NNS of_IN KH2-_NP ,_, KU-_NP ,_, SB-_NP ,_, Y2-_NP ,_, and_CC Y5-inoculated_JJ mice_NNS (_( P_NN >_SYM 0.05_CD in_IN t_NN test_NN )_) ._SENT However_RB ,_, the_DT incubation_NN period_NN of_IN G1-inoculated_JJ mice_NNS was_VBD somewhat_RB shorter_JJR than_IN that_DT of_IN the_DT others_NNS ,_, with_IN a_DT statistically_RB significant_JJ difference_NN between_IN the_DT incubation_NN period_NN of_IN G1-inoculated_JJ mice_NNS and_CC that_IN of_IN KH2-_NP ,_, SB-_NP ,_, and_CC Y2-inoculated_JJ mice_NNS (_( P_NN <_SYM 0.05_CD in_IN t_NN test_NN )_) ._SENT The_DT sheep_NN A1_JJ and_CC B3_NP received_VBD the_DT same_JJ brain_NN homogenate_NN from_IN a_DT naturally_RB occurring_VBG sheep_NN scrapie_NN isolate_NN by_IN intravenous_JJ injection_NN ._SENT The_DT transmission_NN of_IN this_DT parental_JJ isolate_NN of_IN A1_JJ and_CC B3_JJ directly_RB to_TO mice_NNS was_VBD achieved_VBN within_IN 271_CD to_TO 307_CD dpi_NNS ,_, consistent_JJ with_IN the_DT incubation_NN periods_NNS observed_VBD in_IN A1-_NP and_CC B3-inoculated_JJ mice_NNS ._SENT Thus_RB ,_, the_DT first-pass_NN scrapie_NN samples_NNS A1_JJ and_CC B3_NP and_CC their_PP$ parental_JJ isolate_NN all_RB possessed_VBD the_DT ability_NN to_TO transmit_VB to_TO mice_NNS with_IN relatively_RB short_JJ incubation_NN periods_NNS ._SENT In_IN contrast_NN ,_, the_DT S1_NP ,_, S2_NP ,_, and_CC S3_NP scrapie_NP isolates_NNS were_VBD virtually_RB nontransmissible_JJ to_TO ICR_NP mice_NNS ._SENT One_CD mouse_NN inoculated_VBN with_IN the_DT brain_NN homogenate_NN of_IN sheep_NN S1_NP died_VBD at_IN 359_CD dpi_NNS without_IN typical_JJ symptoms_NNS of_IN scrapie_NN but_CC was_VBD positive_JJ for_IN PrPSc_NP in_IN the_DT brain_NN ._SENT We_PP cannot_MD confirm_VB whether_IN this_DT one_CD case_NN is_VBZ due_JJ to_TO actual_JJ transmission_NN or_CC contamination_NN with_IN a_DT mouse-adapted_JJ scrapie_NN agent_NN ._SENT Several_JJ ICR_NP mice_NNS inoculated_VBN with_IN the_DT brain_NN homogenates_NNS of_IN S2_NP or_CC S3_NP sheep_NN died_VBD without_IN typical_JJ symptoms_NNS of_IN scrapie_NN during_IN the_DT observation_NN period_NN but_CC were_VBD also_RB negative_JJ for_IN PrPSc_NP ._SENT Therefore_RB ,_, it_PP is_VBZ obvious_JJ that_IN S1_NP ,_, S2_NP ,_, and_CC S3_NP differ_VBP from_IN the_DT other_JJ scrapie_NN isolates_NNS used_VBN here_RB ._SENT Furthermore_RB ,_, isolate_VBP S3_NP did_VBD not_RB transmit_VB to_TO I/LnJ_NP mice_NNS (_( PrP_NP allotype_NP ,_, PrPB/B_NP )_) ,_, whereas_IN transmission_NN of_IN isolate_NN KH2_NP to_TO these_DT mice_NNS was_VBD confirmed_VBN by_IN the_DT detection_NN of_IN PrPSc_NP at_IN 275_CD dpi_NNS ._SENT The_DT sheep_NN S1_NP ,_, S2_NP ,_, and_CC S3_NP were_VBD born_VBN on_IN the_DT same_JJ farm_NN and_CC in_IN the_DT same_JJ parturient_JJ season_NN from_IN two_CD ewes_NNS that_WDT developed_VBD scrapie_JJ several_JJ months_NNS after_IN delivery_NN ,_, and_CC thus_RB the_DT sheep_NN were_VBD potentially_RB infected_VBN with_IN the_DT same_JJ agent_NN ._SENT One_CD explanation_NN for_IN the_DT failure_NN of_IN the_DT transmission_NN of_IN these_DT isolates_NNS to_TO mice_NNS is_VBZ that_IN the_DT brain_NN homogenates_NNS may_MD possess_VB a_DT relatively_RB low_JJ degree_NN of_IN infectivity_NN ._SENT However_RB ,_, dot_VBP blot_NN analysis_NN of_IN serial_JJ dilutions_NNS of_IN brain_NN homogenates_NNS revealed_VBD that_IN variations_NNS in_IN the_DT amount_NN of_IN PrPSc_NP in_IN the_DT homogenates_NNS appear_VBP to_TO be_VB less_JJR than_IN fourfold_RB among_IN the_DT samples_NNS tested_VBD ,_, suggesting_VBG that_IN the_DT lack_NN of_IN transmission_NN was_VBD not_RB due_JJ to_TO reduced_VBN degrees_NNS of_IN infectivity_NN ._SENT Therefore_RB ,_, we_PP conclude_VBP that_IN the_DT sheep_NN scrapie_NN isolates_VBZ S1_NP ,_, S2_NP ,_, and_CC S3_NP have_VBP an_DT extremely_RB low_JJ ,_, if_IN any_DT ,_, transmissibility_NN to_TO mice_NNS ._SENT PK_NP resistance_NN of_IN sheep_NN PrPSc_NP ._SENT |_SYM Since_IN some_DT TSE_NP strains_NNS are_VBP known_VBN to_TO differ_VB in_IN the_DT relative_JJ PK_NP resistance_NN of_IN PrPSc_NP ,_, we_PP analyzed_VBD the_DT PK_NP resistance_NN of_IN PrPSc_NP in_IN the_DT brains_NNS of_IN sheep_NN with_IN scrapie_NN in_IN order_NN to_TO identify_VB any_DT biochemical_JJ differences_NNS among_IN sheep_NN scrapie_NN isolates_NNS ._SENT Partially_RB purified_VBN PrPSc-containing_NP fractions_NNS without_IN PK_NP treatment_NN were_VBD first_RB analyzed_VBN by_IN immunoblot_NN ,_, and_CC following_VBG densitometric_JJ analysis_NN to_TO allow_VB normalization_NN of_IN the_DT amount_NN of_IN PrPSc_NP among_IN the_DT samples_NNS ,_, the_DT fractions_NNS were_VBD digested_VBN with_IN PK_NP at_IN 0_CD ,_, 8_CD ,_, 40_CD ,_, 200_CD ,_, and_CC 1,000_CD mug/ml_NN for_IN 2_CD h_NN ._SENT The_DT bands_NNS of_IN PrPSc_NP were_VBD clearly_RB detected_VBN after_IN PK_NP treatment_NN at_IN 40_CD mug/ml_NN in_IN KH2_NP and_CC S2_NP ,_, while_IN PrPSc_NP in_IN A1_JJ was_VBD undetectable_JJ under_IN the_DT same_JJ digest_NN conditions_NNS ._SENT To_TO confirm_VB this_DT difference_NN ,_, the_DT same_JJ fractions_NNS were_VBD treated_VBN with_IN PK_NP at_IN 40_CD mug/ml_NN for_IN various_JJ time_NN periods_NNS ._SENT Consistent_JJ with_IN the_DT result_NN in_IN Fig._NN ,_, the_DT PrPSc_NP bands_NNS in_IN the_DT A1_JJ fraction_NN were_VBD virtually_RB eliminated_VBN by_IN a_DT 2-h_JJ treatment_NN with_IN 40-mug/ml_JJ of_IN PK_NP ,_, while_IN the_DT PrPSc_NP bands_NNS in_IN the_DT KH2_NP and_CC S2_NP fractions_NNS were_VBD readily_RB detected_VBN after_IN the_DT same_JJ treatment_NN ._SENT The_DT PrPSc_NP of_IN B3_NP exhibited_VBD the_DT same_JJ PK_NP resistance_NN as_IN A1_JJ ,_, while_IN KU_NP ,_, SB_NP ,_, Y2_NP ,_, Y5_NP ,_, S1_NP ,_, and_CC S3_NP showed_VBD levels_NNS of_IN PK_NP resistance_NN similar_JJ to_TO KH2_NP and_CC S2_NP (_( data_NN not_RB shown_VBN )_) ._SENT Thus_RB ,_, the_DT sheep_NN scrapie_NN isolates_VBZ used_VBN here_RB appeared_VBD to_TO be_VB divided_VBN into_IN two_CD groups_NNS based_VBN on_IN the_DT relative_JJ PK_NP resistance_NN of_IN PrPSc_NP ._SENT One_PP possesses_VBZ PrPSc_NN that_WDT is_VBZ highly_RB resistant_JJ to_TO PK_NP digestion_NN ,_, as_RB defined_VBN by_IN resistance_NN to_TO treatment_NN with_IN PK_NP at_IN 40_CD mug/ml_NN for_IN 2_CD h_NN ,_, and_CC the_DT other_JJ possesses_VBZ PrPSc_NP of_IN relatively_RB low_JJ PK_NP resistance_NN and_CC is_VBZ completely_RB degraded_VBN under_IN these_DT conditions_NNS ._SENT Together_RB ,_, the_DT mouse_NN transmission_NN and_CC PrPSc_NP PK_NP resistance_NN data_NNS can_MD be_VB used_VBN to_TO further_RBR divide_VB the_DT sheep_NN scrapie_NN isolates_VBZ into_IN three_CD groups_NNS ._SENT The_DT first_JJ group_NN includes_VBZ KH2_NP ,_, KU_NP ,_, SB_NP ,_, Y2_NP ,_, Y5_NP ,_, and_CC G1_NP ,_, which_WDT are_VBP transmissible_JJ to_TO ICR_NP mice_NNS with_IN incubation_NN periods_NNS of_IN similar400_JJ days_NNS and_CC contain_VB PrPSc_NP with_IN relatively_RB high_JJ PK_NP resistance_NN ._SENT The_DT second_JJ group_NN includes_VBZ S1_NP ,_, S2_NP ,_, and_CC S3_NP ,_, which_WDT transmit_VBP poorly_RB to_TO mice_NNS but_CC possess_VB PrPSc_NP with_IN a_DT relative_JJ PK_NP resistance_NN similar_JJ to_TO the_DT first_JJ group_NN ._SENT The_DT last_JJ group_NN includes_VBZ A1_JJ ,_, B3_NP ,_, and_CC probably_RB their_PP$ parental_JJ isolate_NN ,_, which_WDT are_VBP transmissible_JJ to_TO ICR_NP mice_NNS with_IN incubation_NN periods_NNS of_IN similar230_JJ days_NNS and_CC possess_VB PrPSc_NP with_IN relatively_RB low_JJ PK_NP resistance_NN ._SENT PK_NP resistance_NN of_IN PrPSc_NP in_IN mice_NNS inoculated_VBN with_IN sheep_NN scrapie_NN ._SENT |_SYM Sheep_NP scrapie_NN isolates_NNS which_WDT transmitted_VBD to_TO ICR_NP mice_NNS segregated_VBD into_IN two_CD groups_NNS based_VBN on_IN incubation_NN periods_NNS ,_, and_CC interestingly_RB ,_, the_DT grouping_NN of_IN sheep_NN scrapie_NN isolates_VBZ by_IN relative_JJ PK_NP resistance_NN of_IN PrPSc_NP in_IN sheep_NN brains_NNS appears_VBZ to_TO coincide_VB with_IN the_DT grouping_NN by_IN incubation_NN periods_NNS ._SENT To_TO address_VB the_DT question_NN of_IN whether_IN the_DT phenotype_NN of_IN relative_JJ PK_NP resistance_NN of_IN PrPSc_NP in_IN sheep_NN brain_NN is_VBZ conserved_VBN in_IN infected_JJ mice_NNS ,_, the_DT relative_JJ PK_NP resistance_NN of_IN PrPSc_NP in_IN the_DT mouse_NN brains_NNS was_VBD also_RB examined_VBN ._SENT PrPSc_NN in_IN the_DT brain_NN of_IN a_DT mouse_NN inoculated_VBN with_IN KH2_NP was_VBD resistant_JJ to_TO treatment_NN with_IN PK_NP at_IN 200_CD mug/ml_NN for_IN 1_CD h_NN ,_, while_IN PrPSc_NP in_IN the_DT brain_NN of_IN a_DT mouse_NN inoculated_VBN with_IN A1_JJ was_VBD sensitive_JJ to_TO this_DT condition_NN ._SENT This_DT difference_NN in_IN the_DT relative_JJ PK_NP resistance_NN was_VBD also_RB confirmed_VBN by_IN the_DT experiments_NNS in_IN Fig._NN ,_, in_IN which_WDT the_DT samples_NNS were_VBD treated_VBN with_IN PK_NP at_IN 200_CD mug/ml_NN for_IN the_DT various_JJ time_NN periods_NNS indicated_VBD ._SENT PrPSc_NN in_IN the_DT brains_NNS of_IN mice_NNS inoculated_VBN with_IN KU_NP and_CC Y5_NP showed_VBD the_DT same_JJ PK_NP resistance_NN as_IN that_DT of_IN a_DT KH2-inoculated_JJ mouse_NN ,_, whereas_IN PrPSc_NP in_IN the_DT brain_NN of_IN a_DT mouse_NN inoculated_VBN with_IN B3_NP showed_VBD the_DT same_JJ PK_NP resistance_NN as_IN that_DT of_IN an_DT A1-inoculated_JJ mouse_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Therefore_RB ,_, the_DT relative_JJ PK_NP resistance_NN of_IN PrPSc_NP generated_VBD in_IN the_DT brains_NNS of_IN mice_NNS was_VBD similar_JJ to_TO that_DT of_IN PrPSc_NP in_IN the_DT inoculum_NN of_IN the_DT corresponding_JJ sheep_NN ._SENT FIG._NN 1_CD ._SENT |_SYM Dot_NP blot_NN analysis_NN of_IN sheep_NN brain_NN homogenates_NNS for_IN the_DT presence_NN of_IN PrPSc_NP ._SENT Dot_NN blot_NN analysis_NN of_IN sheep_NN brain_NN homogenates_NNS for_IN the_DT presence_NN of_IN PrPSc_NP ._SENT Serial_JJ twofold_JJ dilutions_NNS of_IN sheep_NN brain_NN homogenates_NNS used_VBN for_IN inoculation_NN into_IN mice_NNS were_VBD dotted_VBN onto_IN a_DT nitrocellulose_NN membrane_NN and_CC stained_VBN with_IN B-103_NP anti-PrP_NP synthetic_JJ peptide_NN rabbit_NN serum_NN and_CC ECL_NP Western_NP blot_NN detection_NN reagent_NN (_( Amersham_NP )_) ._SENT The_DT sheep_NN are_VBP indicated_VBN at_IN the_DT bottom_NN and_CC dilutions_NNS are_VBP on_IN the_DT right_NN ._SENT In_IN this_DT dot_NN blot_NN analysis_NN ,_, S1_NP appears_VBZ to_TO be_VB negative_JJ for_IN PrPSc_NP ;_: however_RB ,_, PrPSc_NP was_VBD detected_VBN in_IN the_DT immunoblot_NN analysis_NN (_( data_NNS not_RB shown_VBN )_) ._SENT FIG._NN 2_CD ._SENT |_SYM Relative_NP PK_NP resistance_NN of_IN sheep_NN PrPSc_NP ._SENT Relative_JJ PK_NP resistance_NN of_IN sheep_NN PrPSc_NP ._SENT (_( a_DT )_) PrPSc-containing_NN fractions_NNS prepared_VBN from_IN sheep_NN brains_NNS were_VBD treated_VBN with_IN various_JJ concentrations_NNS of_IN PK_NP (_( 0_CD to_TO 1,000_CD mug/ml_NN ,_, indicated_VBN above_IN the_DT photo_NN )_) at_IN 37C_JJ for_IN 2_CD h._JJ Molecular_JJ mass_NN markers_NNS are_VBP indicated_VBN ._SENT PrP_NP was_VBD detected_VBN by_IN immunoblotting_VBG with_IN PrP-specific_JJ antibody_NN and_CC ECL_NN ._SENT (_( b_LS )_) The_DT same_JJ PrPSc-containing_NN fractions_NNS as_RB used_VBN in_IN panel_NN a_DT were_VBD treated_VBN with_IN PK_NP (_( 200_CD mug/ml_NN )_) at_IN 37C_JJ for_IN various_JJ times_NNS (_( 0_CD to_TO 16_CD h_NN ,_, indicated_VBN above_IN the_DT photo_NN )_) ._SENT FIG._NN 3_CD ._SENT |_SYM Relative_NP PK_NP resistance_NN of_IN PrPSc_NP generated_VBD in_IN mouse_NN brain_NN ._SENT Relative_JJ PK_NP resistance_NN of_IN PrPSc_NP generated_VBD in_IN mouse_NN brain_NN ._SENT (_( a_DT )_) PrPSc-containing_NN fractions_NNS prepared_VBN from_IN mouse_NN brains_NNS were_VBD treated_VBN with_IN various_JJ concentrations_NNS of_IN PK_NP (_( 0_CD to_TO 1,000_CD mug/ml_NN ,_, indicated_VBN above_IN the_DT photo_NN )_) at_IN 37C_JJ for_IN 2_CD h._JJ Molecular_JJ mass_NN markers_NNS are_VBP indicated_VBN ._SENT PrP_NP was_VBD detected_VBN by_IN immunoblotting_VBG as_RB in_IN Fig._NN ._SENT (_( b_LS )_) The_DT same_JJ PrPSc-containing_NN fractions_NNS as_RB used_VBN in_IN panel_NN a_DT were_VBD treated_VBN with_IN PK_NP (_( 200_CD mug/ml_NN )_) at_IN 37C_JJ for_IN various_JJ times_NNS (_( 0_CD to_TO 16_CD h_NN ,_, indicated_VBN above_IN the_DT photo_NN )_) ._SENT TABLE_NN 1_CD |_SYM Sheep_NP used_VBN in_IN this_DT study_NN TABLE_NP 2_CD |_SYM Transmissibility_NN of_IN sheep_NN scrapie_NN to_TO mice_NNS TABLE_NP 3_CD |_SYM Grouping_NN of_IN sheep_NN scrapie_NN samples_NNS based_VBN on_IN transmissibility_NN to_TO mice_NNS and_CC relative_JJ PK_NP resistance_NN of_IN PrPSc_NP We_PP were_VBD interested_JJ in_IN characterizing_VBG the_DT scrapie_NN strains_NNS prevalent_JJ in_IN Japan_NP ._SENT In_IN the_DT absence_NN of_IN known_VBN biological_JJ clones_NNS (_( which_WDT would_MD take_VB many_JJ years_NNS to_TO develop_VB )_) ,_, we_PP attempted_VBD to_TO gain_VB information_NN about_IN the_DT nature_NN of_IN these_DT strains_NNS by_IN examining_VBG the_DT biological_JJ and_CC biochemical_JJ properties_NNS of_IN a_DT panel_NN of_IN isolates_NNS and_CC showed_VBD that_IN at_IN least_JJS three_CD types_NNS of_IN scrapie_NN strains_NNS exist_VBP in_IN Japan_NP ._SENT It_PP is_VBZ thought_VBN that_IN the_DT scrapie_NN agent_NN entered_VBN into_IN Japan_NP along_IN with_IN imported_VBN sheep_NN in_IN the1970s_NNS ._SENT Since_IN the_DT recognition_NN of_IN the_DT first_JJ scrapie_NN case_NN early_RB in_IN the1980s_NNS ,_, similar60_JJ scrapie_NN cases_NNS have_VBP been_VBN officially_RB reported_VBN so_RB far_RB ._SENT Thus_RB ,_, our_PP$ data_NNS indicate_VBP the_DT possibility_NN that_IN the_DT primary_JJ scrapie_NN strain_NN has_VBZ already_RB exhibited_VBN considerable_JJ variation_NN during_IN the_DT past_JJ quarter_NN century_NN ._SENT However_RB ,_, it_PP is_VBZ unknown_JJ if_IN the_DT current_JJ repertoire_NN of_IN scrapie_NN strains_NNS is_VBZ derived_VBN from_IN a_DT single_JJ parental_JJ strain_NN that_WDT has_VBZ been_VBN changing_VBG during_IN its_PP$ spread_NN through_IN the_DT sheep_NN population_NN ,_, similar_JJ to_TO the_DT mutation-like_JJ change_NN found_VBN on_IN serial_JJ transmission_NN of_IN the_DT scrapie_NN agent_NN in_IN experimental_JJ animals_NNS ._SENT Alternatively_RB ,_, multiple_JJ infection_NN is_VBZ likely_JJ to_TO occur_VB in_IN natural_JJ scrapie_NN ,_, so_RB that_IN it_PP is_VBZ also_RB possible_JJ that_IN multiple_JJ strains_NNS have_VBP entered_VBN into_IN Japan_NP with_IN imported_VBN sheep_NN ._SENT The_DT diversity_NN of_IN sheep_NN scrapie_NN strains_NNS in_IN Japan_NP seems_VBZ similar_JJ to_TO that_DT described_VBN in_IN the_DT United_NP Kingdom_NP based_VBN on_IN transmissibility_NN to_TO mice_NNS ,_, because_IN some_DT isolates_NNS were_VBD essentially_RB nontransmissible_JJ whereas_IN others_NNS were_VBD readily_RB transmissible_JJ to_TO PrPA/A_NP mice_NNS with_IN incubation_NN periods_NNS of_IN >350_JJ days_NNS ._SENT However_RB ,_, to_TO our_PP$ knowledge_NN ,_, sheep_NN scrapie_NN which_WDT successfully_RB transmits_VBZ to_TO mice_NNS with_IN an_DT average_JJ incubation_NN period_NN of_IN similar230_JJ days_NNS ,_, like_IN A1_JJ and_CC B3_NP ,_, has_VBZ an_DT extremely_RB short_JJ incubation_NN period_NN in_IN primary_JJ transmission_NN ._SENT TSE_NN agents_NNS have_VBP been_VBN characterized_VBN by_IN transmissibility_NN to_TO experimental_JJ animals_NNS and_CC distribution_NN of_IN neuropathological_JJ lesions_NNS ._SENT In_IN addition_NN ,_, biochemical_JJ characterization_NN of_IN PrPSc_NP seems_VBZ to_TO be_VB useful_JJ for_IN discriminating_VBG between_IN TSE_NP strains_NNS ._SENT For_IN example_NN ,_, two_CD hamster-adapted_JJ transmissible_JJ mink_NN encephalopathy_NN strains_NNS ,_, "_`` Hyper_NN "_'' and_CC "_`` Drowsy_NP ,_, "_`` can_MD be_VB distinguished_VBN from_IN each_DT other_JJ not_RB only_RB by_IN incubation_NN period_NN and_CC neuropathology_NN but_CC also_RB by_IN the_DT relative_JJ PK_NP resistance_NN and_CC molecular_JJ mass_NN of_IN PrPSc_NP ._SENT Here_RB we_PP found_VBD that_IN relative_JJ PK_NP resistance_NN of_IN PrPSc_NP is_VBZ likely_JJ to_TO be_VB useful_JJ for_IN the_DT distinction_NN of_IN sheep_NN scrapie_NN strains_NNS to_TO some_DT extent_NN ,_, as_IN the_DT samples_NNS we_PP analyzed_VBD could_MD be_VB divided_VBN into_IN two_CD groups_NNS based_VBN on_IN relative_JJ PK_NP resistance_NN ._SENT Recently_RB ,_, the_DT ratio_NN of_IN glycosylated_JJ PrPSc_NP bands_NNS was_VBD used_VBN to_TO distinguish_VB vCJD_NNS from_IN other_JJ types_NNS of_IN CJD_NN ,_, and_CC sheep_NN scrapie_NN can_MD be_VB divided_VBN into_IN several_JJ groups_NNS by_IN using_VBG this_DT glycoform_NN typing_VBG of_IN PrPSc_NP ._SENT In_IN general_JJ ,_, strain_VB typing_VBG approaches_NNS using_VBG a_DT combination_NN of_IN different_JJ properties_NNS provide_VBP a_DT more_RBR reliable_JJ means_NNS of_IN strain_NN differentiation_NN ._SENT Analyses_NNS of_IN biochemical_JJ properties_NNS of_IN PrPSc_NN are_VBP less_RBR time-consuming_JJ than_IN bioassays_NNS in_IN mice_NNS ,_, and_CC therefore_RB ,_, it_PP is_VBZ advantageous_JJ to_TO use_VB a_DT combination_NN of_IN several_JJ biochemical_JJ properties_NNS such_JJ as_IN relative_JJ PK_NP resistance_NN ,_, molecular_JJ mass_NN ,_, and_CC glycoform_NN typing_VBG of_IN PrPSc_NP ,_, to_TO achieve_VB more_RBR definitive_JJ strain_NN typing_VBG ._SENT A_DT recent_JJ study_NN using_VBG 10_CD sheep_NN with_IN scrapie_NN in_IN the_DT United_NP States_NPS showed_VBD a_DT perfect_JJ correlation_NN between_IN the_DT detection_NN of_IN PrPSc_NP in_IN sheep_NN brain_NN and_CC transmissibility_NN to_TO mice_NNS ._SENT In_IN contrast_NN ,_, it_PP is_VBZ well-known_JJ that_IN some_DT sheep_NN scrapie_NN strains_NNS are_VBP difficult_JJ to_TO transmit_VB to_TO mice_NNS ._SENT In_IN this_DT study_NN ,_, we_PP showed_VBD that_IN scrapie_NN strains_NNS classified_VBN into_IN groups_NNS 1_CD and_CC 2_CD differed_VBN in_IN their_PP$ transmissibility_NN to_TO mice_NNS but_CC were_VBD indistinguishable_JJ by_IN the_DT relative_JJ PK_NP resistance_NN of_IN PrPSc_NP ._SENT The_DT discrepancy_NN between_IN the_DT presence_NN of_IN PrPSc_NP and_CC the_DT transmissibility_NN to_TO mice_NNS may_MD imply_VB that_IN factors_NNS other_JJ than_IN PrPSc_NP are_VBP involved_VBN in_IN determining_VBG the_DT infectivity_NN or_CC that_IN PrPSc_NP is_VBZ not_RB the_DT molecule_NN responsible_JJ for_IN infectivity_NN ._SENT Alternatively_RB ,_, strain-specific_JJ conformations_NNS of_IN PrPSc_NP have_VBP been_VBN shown_VBN ,_, and_CC so_RB it_PP is_VBZ also_RB conceivable_JJ that_IN subtle_JJ differences_NNS in_IN biochemical_JJ and/or_CC biophysical_JJ properties_NNS of_IN PrPSc_NP which_WDT cannot_MD be_VB detected_VBN by_IN PK_NP digestion_NN may_MD influence_VB the_DT transmissibility_NN to_TO mice_NNS ._SENT It_PP is_VBZ also_RB possible_JJ that_IN the_DT sheep_NN PrP_NP genotype_NN may_MD explain_VB the_DT discrepancy_NN ._SENT It_PP has_VBZ not_RB yet_RB been_VBN clarified_VBN whether_IN amino_NN acid_NN sequences_NNS of_IN sheep_NN PrPSc_NP influence_NN transmission_NN to_TO mice_NNS ._SENT Here_RB we_PP showed_VBD that_IN scrapie_NN occurring_VBG in_IN sheep_NN homozygous_JJ for_IN PrPMARQ_NP transmitted_VBD to_TO mice_NNS (_( e.g._FW ,_, SB_NP ,_, Y2_NP ,_, Y5_NP ,_, A1_JJ ,_, and_CC G1_NP )_) ._SENT This_DT indicates_VBZ that_IN sheep_NN PrPSc_NN composed_VBN of_IN the_DT product_NN of_IN the_DT PrPMARQ_NP allele_NN could_MD initiate_VB the_DT accumulation_NN of_IN PrPSc_NP in_IN mice_NNS by_IN using_VBG mouse_NN PrPC_NN as_IN a_DT substrate_NN ._SENT However_RB ,_, there_EX are_VBP differences_NNS in_IN the_DT incubation_NN periods_NNS for_IN A1_JJ between_IN these_DT sheep_NN and_CC other_JJ sheep_NN possessing_VBG the_DT PrPMARQ/MARQ_NP genotype_NN ,_, and_CC more_RBR recently_RB ,_, it_PP was_VBD reported_VBN that_IN one_CD scrapie_NN case_NN occurring_VBG in_IN PrPARQ/ARQ_NP sheep_NN (_( amino_NN acid_NN polymorphisms_NNS at_IN codon_NN 112_CD was_VBD unavailable_JJ )_) was_VBD virtually_RB nontransmissible_JJ to_TO mice_NNS ,_, suggesting_VBG the_DT amino_NN acid_NN sequence_NN of_IN sheep_NN PrPSc_NP is_VBZ not_RB the_DT sole_JJ determinant_NN of_IN the_DT transmissibility_NN to_TO mice_NNS ._SENT Among_IN the_DT sheep_NN with_IN scrapie_NN used_VBN here_RB ,_, S1_NP ,_, S2_NP ,_, and_CC S3_NP differed_VBD in_IN clinical_JJ course_NN from_IN other_JJ sheep_NN by_IN death_NN at_IN a_DT young_JJ age_NN and_CC hypersensitivity_NN ._SENT The_DT simple_JJ explanation_NN for_IN this_DT is_VBZ that_IN the_DT strain(s)_NN infecting_VBG these_DT sheep_NN differs_VBZ from_IN those_DT of_IN the_DT other_JJ scrapie_NN cases_NNS ,_, and_CC indeed_RB ,_, these_DT agents_NNS obviously_RB differed_VBD from_IN the_DT others_NNS in_IN transmissibility_NN to_TO mice_NNS ._SENT Scrapie_NN strains_NNS adapted_VBN to_TO rodents_NNS exhibit_VBP strain-specific_JJ clinical_JJ symptoms_NNS ,_, neuropathological_JJ lesions_NNS ,_, and_CC incubation_NN periods_NNS ._SENT However_RB ,_, it_PP is_VBZ unclear_JJ whether_IN a_DT given_VBN sheep_NN scrapie_NN strain_NN determines_VBZ strain-specific_JJ clinical_JJ and/or_CC clinico-pathological_JJ features_NNS ._SENT As_IN described_VBN in_IN Materials_NPS and_CC Methods_NP ,_, these_DT sheep_NN have_VB an_DT immediate_JJ blood_NN relationship_NN and_CC were_VBD kept_VBN on_IN the_DT same_JJ ranch_NN ,_, and_CC so_RB other_JJ factors_NNS such_JJ as_IN genetic_JJ background_NN ,_, breeds_NNS ,_, route_NN of_IN infection_NN ,_, and_CC environment_NN may_MD be_VB involved_VBN in_IN defining_VBG the_DT type_NN of_IN disease_NN in_IN these_DT particular_JJ cases_NNS ._SENT A_DT particular_JJ type_NN of_IN scrapie_NN agent_NN prevalent_JJ in_IN the_DT United_NP Kingdom_NP is_VBZ believed_VBN to_TO have_VB initially_RB caused_VBN BSE_NN ,_, and_CC later_RBR on_RB ,_, this_DT agent_NN passed_VBN to_TO felids_NNS and_CC human_JJ beings_NNS through_IN cattle_NNS ._SENT The_DT diversity_NN of_IN field_NN scrapie_NN isolates_VBZ in_IN Japan_NP is_VBZ similar_JJ to_TO that_WDT reported_VBD in_IN the_DT United_NP Kingdom_NP at_IN least_JJS in_IN terms_NNS of_IN primary_JJ transmission_NN to_TO mice_NNS ._SENT Therefore_RB ,_, at_IN present_JJ ,_, we_PP cannot_MD exclude_VB the_DT possibility_NN of_IN the_DT presence_NN of_IN a_DT scrapie_NN strain_NN in_IN Japan_NP that_WDT possesses_VBZ properties_NNS similar_JJ to_TO the_DT BSE_JJ agent_NN ._SENT Strain_NN typing_VBG using_VBG two_CD mouse_NN strains_NNS ,_, RIII_NP and_CC C57BL_NP ,_, carrying_VBG the_DT PrPA/A_NP allotype_NN appears_VBZ to_TO be_VB one_CD of_IN the_DT methods_NNS to_TO distinguish_VB BSE_NN and_CC BSE-related_JJ TSE_NP agents_NNS from_IN sheep_NN scrapie_NN ._SENT Further_JJR analysis_NN will_MD be_VB required_VBN to_TO investigate_VB whether_IN sheep_NN scrapie_NN strains_NNS in_IN Japan_NP have_VBP the_DT potential_JJ risk_NN to_TO create_VB new_JJ epidemics_NNS like_IN the_DT BSE_JJ agent_NN ._SENT 